Figure 1.
Figure 1. Estimates of overall survival. (A) Kaplan-Meier product-limit estimate of overall survival for patients with newly diagnosed acute myeloid leukemia treated on ECOG protocols between 1973 and 1997. Reprinted with permission.5 (B) Kaplan-Meier product-limit estimate of overall survival for younger patients (ages ≤ 55 years) with newly diagnosed acute myeloid leukemia treated on ECOG protocols between 1973 and 1997. Reprinted with permission.5 (C) Kaplan-Meier product-limit estimate of overall survival for older patients (ages > 55 years) with newly diagnosed acute myeloid leukemia treated on ECOG protocols between 1973 and 1997. From Appelbaum et al.5 Copyright American Society of Hematology, used with permission.

Estimates of overall survival. (A) Kaplan-Meier product-limit estimate of overall survival for patients with newly diagnosed acute myeloid leukemia treated on ECOG protocols between 1973 and 1997. Reprinted with permission. (B) Kaplan-Meier product-limit estimate of overall survival for younger patients (ages ≤ 55 years) with newly diagnosed acute myeloid leukemia treated on ECOG protocols between 1973 and 1997. Reprinted with permission. (C) Kaplan-Meier product-limit estimate of overall survival for older patients (ages > 55 years) with newly diagnosed acute myeloid leukemia treated on ECOG protocols between 1973 and 1997. From Appelbaum et al. Copyright American Society of Hematology, used with permission.

Close Modal

or Create an Account

Close Modal
Close Modal